Smith & Nephew SNATS (SNN) revenue breakdown
By segment, Orthopaedics is the largest at 40% of fiscal 2025 revenue; Advanced Wound Management grew fastest, 5% a year over 8 years.
By product, Orthopaedics, Sports Medicine and Ear Nose and Throat is the largest at 71% of fiscal 2025 revenue; Advanced Wound Management grew fastest, 5% a year over 8 years.
Revenue by segment
Fiscal years, as Smith & Nephew SNATS reports them in its 10-K filings; fiscal 2025 total $6.2B.
| Segments | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Orthopaedics | $2.1B | $2.2B | $2.2B | $1.9B | $2.2B | $2.1B | $2.2B | $2.3B | $2.4B | 40% |
| Sports Medicine & ENT | $1.4B | $1.5B | $1.5B | $1.3B | $1.6B | $1.6B | $1.7B | $1.8B | $1.9B | 31% |
| Advanced Wound Management | $1.3B | $1.3B | $1.4B | $1.3B | $1.5B | $1.5B | $1.6B | $1.7B | $1.8B | 29% |
Revenue by product
Fiscal years, as Smith & Nephew SNATS reports them in its 10-K filings; fiscal 2025 total $6.2B.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Orthopaedics, Sports Medicine and Ear Nose and Throat | — | $3.5B | $3.6B | $3.8B | $3.2B | $3.7B | $3.7B | $3.9B | $4.1B | $4.4B | 71% |
| Advanced Wound Management | — | $1.3B | $1.3B | $1.4B | $1.3B | $1.5B | $1.5B | $1.6B | $1.7B | $1.8B | 29% |
| Knee Implants | $932M | — | — | — | — | — | — | — | — | — | — |
| Advanced Wound Care | $719M | — | — | — | — | — | — | — | — | — | — |
| Arthroscopic Enabling Technologies | $631M | — | — | — | — | — | — | — | — | — | — |
| Hip Implants | $597M | — | — | — | — | — | — | — | — | — | — |
| Sports Medicine Joint Repair | $587M | — | — | — | — | — | — | — | — | — | — |
| Trauma & Extremities | $475M | — | — | — | — | — | — | — | — | — | — |
| Advanced Wound Bioactives | $342M | — | — | — | — | — | — | — | — | — | — |
| Other Surgical Businesses | $214M | — | — | — | — | — | — | — | — | — | — |
| Advanced Wound Devices | $172M | — | — | — | — | — | — | — | — | — | — |
Questions
Where does Smith & Nephew SNATS make its money?
In fiscal 2025, by segment: Orthopaedics $2.4B, Sports Medicine & ENT $1.9B, Advanced Wound Management $1.8B.
From Smith & Nephew SNATS's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.